i have to be honest, i'm getting the impression that the FDA has a very clear process and Cytodyn is not really submitting protocols that follow the process. Each indication needs a control group, each needs a safety study to show patients won't die, etc.. i was under the impression that the FDA was good with what Cytodyn is moving forward on from the CC last month, how can one phone call from the FDA cancel a whole indication? Is Cytodyn simply telling us good news before the FDA has any opinion or statement about it? seems sloppy to me. Good news is not moving the stock price as it should, i hope this news is not too damaging.
Market Data 
Markets 
AI
